Faculty Information - Anraku Makoto

Anraku Makoto

Department / Course FACULTY OF PHARMACEUTICAL SCIENCES Department of Pharmaceutical Sciences

Job

Book and thesis
1.	2022	Books	Utilization of agro-industrial and food by-products for the production of amphiphilic proteins and peptides Elisevier (Co-authored)
2.	2022	Papers	The Effects of Sacran, a Sulfated Polysaccharide, on Gut Microbiota Using Chronic Kidney Disease Model Rats Biological & Pharmaceutical Bulletin (Co-authored)
3.	2021	Papers	Supramolecular Assembly of Hybrid Pt(II) Porphyrin/Tomatine Analogues with Different Nanostructures and Cytotoxic Activities ACS Omega (Co-authored)
4.	2021	Papers	Interspecies differences in gastrointestinal physiology affecting the in vivo performance of oral pharmaceutical solid dosage forms Journal of Drug Delivery Science and Technology (Co-authored)
5.	2021	Books	Preparation of Chitin Nanofiber and Its Derivatives from Crab Shell and Their Efficient Biological Properties In book: Chitosan for Biomaterials III (Co-authored)
6.	2021	Papers	Sacran, a sulfated polysaccharide, suppresses the absorption of lipids and modulates the intestinal flora in non-alcoholic steatohepatitis model rats 268,pp.118991 (Co-authored)
7.	2021	Papers	The preparation and validation of chitosan tablets that rapidly disperse and disintegrate as an oral adsorbent in the treatment of lifestyle-related diseases Carbohydr Polym . 123,pp.117246 (Co-authored)
8.	2020	Papers	Antioxidative Potency of Dolphin Serum Albumin Is Stronger Than That of Human Serum Albumin Irrespective of Substitution of 34Cysteine With Serine Frontiers in Physiology (Co-authored)
9.	2020	Papers	Antioxidative Potency of Dolphin Serum Albumin Is Stronger Than That of Human Serum Albumin Irrespective of Substitution of 34 Cysteine With Serine Front Physiol . 2 (11),pp.598451 (Co-authored)
10.	2020	Papers	Glycosylation decreases aggregation and immunogenicity of adalimumab fab secreted from Pichia pastoris J Biochem. (Co-authored)
11.	2020	Books	Handbook of chitin and chitosan; vol.3: chitin and chitosan based polymer materials for various applications -Chapter 18 - Future aspects of biomedical applications of chitin and chitosan in diseases associated with oxidative stress- Science direct,pp.589-608 (Co-authored)
12.	2020	Papers	Effects of surface-deacetylated chitin nanofibers on non-alcoholic steatohepatitis model rats and their gut microbiota International journal of biological macromolecule 164,pp.659-666 (Co-authored)
13.	2020	Papers	A thermoresponsive hydrophobically modified hydroxypropylmethylcellulose/cyclodextrin injectable hydrogel for the sustained release of drugs International Journal of Pharmaceutics (Amsterdam, Netherlands) 575,pp.118845 (Co-authored)
14.	2020	Papers	C-Terminal Cysteine PEGylation of Adalimumab Fab with an Engineered Interchain SS Bond Biological & pharmaceutical bulletin 43 (3),pp.418-423 (Co-authored)
15.	2020	Papers	Morphometric analysis of paramylon particles produced by Euglena gracilis EOD-1 using FIB/SEM tomography Chemical & pharmaceutical bulletin (Co-authored)
16.	2020	Papers	In vitro transdermal permeation behavior of isosorbide dinitrate in the absence and presence of 2-hydroxypropyl-β-cyclodextrin: solutions and suspensions Journal of Inclusion Phenomena and Macrocyclic Chemistry (Co-authored)
17.	2019	Papers	Design and Evaluation of An Extended-Release Olmesartan Tablet Using Chitosan/Cyclodextrin Composites Pharmaceutics 11,pp.82 (Co-authored)
18.	2019	Papers	The Use of Enteric Capsules for Releasing a Fragrance over an Extended Period of Tim Chemical & pharmaceutical bulletin 67 (5),pp.493-497 (Co-authored)
19.	2019	Papers	Modification of Drug Crystallization by Cyclodextrins in Pre-Formulation Study Chem. Pharm. Bull (Co-authored)
20.	2019	Papers	Physiologically Stable Hydrophilic C60 Nanoparticles for Photodynamic Therapy 2,pp.716-725 (Co-authored)
21.	2019	Papers	Preparation and evaluation of freeze dried surface-deacetylated chitin nanofiber/sacran pellets for use as an extended-release excipient Int. J. Biol. Macromol 124,pp.888-894 (Co-authored)
22.	2018	Papers	Antioxidant activities of chitosans and its derivatives in in vitro and in vivo studies. Carbohydr Polym 199,pp.141-149 (Co-authored)
23.	2018	Papers	Sacran, a High-molecular Weight Polysaccharide Inhibits Renal Injury and Oxidative Stress in Chronic Renal Failure Model Rats Journal of Nutritional Biology 4,pp.267-275 (Co-authored)
24.	2018	Papers	Metal-catalyzed oxidation of human serum albumin does not alter the interactive binding to the two principal drug binding sites. Biochem Biophys Rep 14,pp.155-160 (Co-authored)
25.	2018	Papers	Release control of fragrances by complexation with β-cyclodextrin and its derivatives Journal of Inclusion Phenomena and Macrocyclic Chemistry 92(1-2),pp.147-155 (Co-authored)
26.	2018	Papers	Glucose Responsive Rheological Change and Drug Release from a Novel Worm-like Micelle Gel Formed in Cetyltrimethylammonium Bromide/Phenylboronic Acid/Water System. Mol Pharm. (Co-authored)
27.	2017	Papers	Surface-deacetylated chitin nanofibers reinforced with a sulfobutyl ether β-cyclodextrin gel loaded with prednisolone as potential therapy for inflammatory bowel disease. Carbohydr Polym. (Co-authored)
28.	2017	Papers	The binding of silibinin, the main constituent of silymarin, to site I on human serum albumin Biological & Pharmaceutical Bulletin (Co-authored)
29.	2017	Papers	Hydrophobically Modified Polymer/α-Cyclodextrin Thermoresponsive Hydrogels for Use in Ocular Drug Delivery. Mol Pharm. (Co-authored)
30.	2017	Papers	Crystallographic analysis of the ternary complex of octanoate and N-acetyl-l-methionine with human serum albumin reveals the mode of their stabilizing interactions. Biochim Biophys Acta (Co-authored)
31.	2017	Papers	An oral absorbent, surface-deacetylated chitin nano-fiber ameliorates renal injury and oxidative stress in 5/6 nephrectomized rats. Carbohydr Polym (Co-authored)
32.	2016	Papers	The formation of an inclusion complex between a metabolite of ginsenoside, compound K and γ-cyclodextrin and its dissolution characteristics. J Pharm Pharmacol (Co-authored)
33.	2016	Papers	Comparison of Posttranslational Modification and the Functional Impairment of Human Serum Albumin in Commercial Preparations Journal of Pharmaceutical Sciences (Co-authored)
34.	2016	Papers	Antioxidant and renoprotective activity of 2-hydroxypropyl-β-cyclodextrin in nephrectomized rats. J Pharm Pharmacol (Co-authored)
35.	2016	Papers	Antioxidant effects of the hydroxy groups in the simple phenolic carbazoles Heterocycles 92,pp.120-132 (Co-authored)
36.	2016	Papers	Biomaterials based on freeze dried surface-deacetylated chitin nanofibers reinforced with sulfobutyl ether β-cyclodextrin gel in wound dressing applications Int. J. Pharm 511,pp.1080-1087 (Co-authored)
37.	2016	Papers	Effect of a Ferric Citrate Formulation, a Phosphate Binder, on Oxidative Stress in Chronic Kidney Diseases-Mineral and Bone Disorder Patients Receiving Hemodialysis: A Pilot Study Biol. Pharm. Bull 39,pp.1000-1006 (Co-authored)
38.	2016	Papers	In Vitro and In Vivo Evaluation of Hydrophilic C60(OH)10/2-Hydroxypropyl-β-cyclodextrin Nanoparticles as an Antioxidant J. Pharm. Sci 105,pp.2959-2965 (Co-authored)
39.	2016	Papers	N-acetyl-L-methionine is a superior protectant of human serum albumin against post-translational oxidation as compared to N-acetyl-L-tryptophan Biochim. Biophys. Rep 68,pp.608-614 (Co-authored)
40.	2015	Papers	Surface-Deacetylated Chitin Nano-Fiber/Hyaluronic Acid Composites as Potential Antioxidative Compounds for Use in Extended-Release Matrix Tablets. Int J Mol Sci 16,pp.24707-24717 (Co-authored)
41.	2015	Papers	Amino acids of importance for the antioxidant activity of human serum albumin as revealed by recombinant mutants and genetic variants. Life Sci 134,pp.36-41 (Co-authored)
42.	2015	Papers	Olmesartan protects endothelial cells against oxidative stress-mediated cellular injury. Clin Exp Nephrol. (Co-authored)
43.	2015	Papers	Slow-release of famotidine from tablets consisting of chitosan/sulfobutyl ether β-cyclodextrin composites. Int J Pharm 487,pp.142-147 (Co-authored)
44.	2015	Papers	Formation of Elastic Gels from Deacetylated Chitin Nanofibers Reinforced with Sulfobutyl Ether β-Cyclodextrin Chemistry Letters 44,pp.285-287 (Co-authored)
45.	2015	Papers	Preparation of hydrophilic C60(OH)10/2-hydroxypropyl-β-cyclodextrin nanoparticles for the treatment of a liver injury induced by an overdose of acetaminophen. Biomaterials 45,pp.115-123 (Co-authored)
46.	2015	Papers	Cross-linked human serum albumin dimer has the potential for use as a plasma-retaining agent for the fatty acid-conjugated antidiabetic drugs. J Pharm Pharmacol 67,pp.255-63 (Co-authored)
47.	2015	Books	Human Serum Albumin (HSA): Functional Structure, Synthesis and Therapeutic Uses; Glycative and Oxidative Modification of Human Serum Albumin (Chapter 5),pp.91-112 (Co-authored)
48.	2014	Papers	Elucidation of the mechanism responsible for the oxidation of serum albumin and its application in treating oxidative stress-related diseases,pp.973-970 (Sole-authored)
49.	2014	Papers	Effects of chitosan on oxidative stress and related factors in hemodialysis patients Carbohydr Poly 112,pp.152-157 (Co-authored)
50.	2014	Papers	N-acetyl-L- methionine is a superior protectant of human serum albumin against photo- oxidation and reactive oxygen species compared to N-acetyl-L-tryptophan Biochim Biophys Acta (Co-authored)
51.	2014	Papers	Potential Use of /2-Hydroxypropyl-β-cyclodextrin Nanoparticles as a New Photosensitizer in the Treatment of Cancer International Journal of Photoenergy (Co-authored)
52.	2014	Papers	Preparation and antioxidant activity of PEGylated chitosans with different particle sizes Int J Biol Macromol (Co-authored)
53.	2014	Papers	Antioxidant effects of the highly-substituted carbazole alkaloids and their related carbazoles Bioorg Med Chem Lett (Co-authored)
54.	2014	Papers	Combined use of cyclodextrins and hydroxypropylmethylcellulose stearoxy ether (Sangelose) for the preparation of orally disintegrating tablets of type-2 antidiabetes agent glimepiride Journal of Inclusion Phenomena and Macrocyclic Chemistry (Co-authored)
55.	2014	Papers	Cys34-cysteinylated human serum albumin is a sensitive plasma marker in oxidative stress-related chronic diseases PLoS One (Co-authored)
56.	2014	Papers	Differential effects of methoxy group on the interaction of curcuminoids with two major ligand binding sites of human serum albumin PLoS One (Co-authored)
57.	2013	Papers	Crystallization of a new polymorph of acetohexamide from 2- hydroxybutyl- β-cyclodextrin solution: form VI with a high aqueous solubility Int J Pharm 453,pp.315-321 (Co-authored)
58.	2013	Books	Human serum albumin: The oxidation of human serum albumin and role of Cys34,pp.180-196 (Co-authored)
59.	2013	Papers	Preparation of soluble stable C60-human serum albumin nanoparticles via cyclodextrin complexation and their reactive oxygen production characteristics Life Sci 93,pp.277-272 (Co-authored)
60.	2013	Papers	Redox properties of serum albumin Biochim Biophys Acta 1830,pp.5465-5472 (Co-authored)
61.	2012	Papers	Antioxidant and renoprotective activity of chitosan in nephrectomized rats Carbohydr Poly 89,pp.302-304 (Co-authored)
62.	2012	Papers	Cyclodextrin-induced change in crystal habit of acetylsalicylic acid in aqueous solution Crystal Growth & Design 12,pp.1985-1991 (Co-authored)
63.	2011	Papers	Antioxidant properties of high molecular weight dietary chitosan in vitro and in vivo Carbohydr Poly 83,pp.501-505 (Co-authored)
64.	2011	Papers	Comparison of receptors and enzymes regulating cholesterol levels in liver between SHR/NDmcr-cp rats and normotensive Wistar Kyoto rats at ten weeks of age Biol Pharm Bull 34,pp.1116-1119 (Co-authored)
65.	2011	Papers	Quantitative analysis of cysteine-34 on the anitioxidative properties of human serum albumin in hemodialysis patients J Pharm Sci 100,pp.3968-3976 (Co-authored)
66.	2011	Papers	Spectroscopic studies of interactions of chondroitin sulfates with cisplatin Carbohydr Res 346,pp.631-637 (Co-authored)
67.	2011	Papers	Surveillance study on the needs for self-medication of local residents and community pharmacists in Fukuyama Yakugaku Zasshi 131,pp.1117-1125 (Co-authored)
68.	2011	Papers	Surveillance study on use of over-the-counter drug and health food by school pharmacist for grade-schooler, junior high school student, and high school students. Yakugaku Zasshi 131,pp.835-842 (Co-authored)
69.	2010	Papers	Enhancement of dissolution and bioavailability of flurbiprofen by low molecular weight chitosans Pharmazie 64,pp.461-466 (Co-authored)
70.	2010	Papers	Evaluation of carboxymethyl-β-cyclodextrin with acid function: Improvement of chemical stability, oral bioavailability and bitter taste of famotidine Int J Pharm 397,pp.1-8 (Co-authored)
71.	2010	Papers	High Levels of Oxidative Stress in the Brain of Young Stroke-Prone Spontaneously Hypertensive Rats at Ten Weeks of Age Biol Pharm Bull 33,pp.518-521 (Co-authored)
72.	2010	Papers	Polysaccharides as potential antioxidative compounds for extended-release matrix tablets Carbohydr Res 345,pp.82-86 (Co-authored)
73.	2010	Papers	Superior plasma retention of a cross-linked human serum albumin dimer in nephrotic rats as a new type of plasma expander Drug Metab Dispos 38,pp.2124-2129 (Co-authored)
74.	2010	Papers	The antioxidative and antilipidemic effects of different molecular weight chitosans in metabolic syndrome model rats Biol Pharm Bull 33,pp.1994-1998 (Co-authored)
75.	2010	Papers	Useful Extend-release Chitosan Tablets with High Antioxidant Activity Pharmaceutics 2,pp.245-257 (Co-authored)
76.	2009	Papers	Antioxidant effects of a dietary supplement: reduction of indices of oxidative stress in normal subjects by water-soluble chitosan Food Chem Toxicol 47,pp.104-109 (Co-authored)
77.	2009	Papers	Antioxidant properties of some different molecular weight chitosans Carbohydr Res 344,pp.1690-1696 (Co-authored)
78.	2009	Papers	Evaluation for antioxidant and renoprotective activity of olmesartan using nephrectomy rats Biol Pharm Bull 32,pp.2041-2045 (Co-authored)
79.	2009	Papers	Hemoglobin vesicles, polyethylene glycol (PEG)ylated liposomes developed as a red blood cell substitute, do not induce the accelerated blood clearance phenomenon in mice Drug Metab Dispos 37,pp.2197-2203 (Co-authored)
80.	2009	Papers	Pharmacokinetic study of enclosed hemoglobin and outer lipid component after the administration of hemoglobin vesicles as an artificial oxygen carrier Drug Metab Dispos 37,pp.1456-1463 (Co-authored)
81.	2008	Papers	Antioxidant protection of human serum albumin by chitosan Int J Biol Macromol 43,pp.159-164 (Co-authored)
82.	2008	Papers	CD36 is one of important receptors promoting renal tubular injury by advanced oxidation protein products Am J Physiol Renal Physiol 295,pp.F1871-1880 (Co-authored)
83.	2008	Papers	Effect of intravenous iron administration frequency on AOPP and inflammatory biomarkers in chronic hemodialysis patients: a pilot study Clin Biochem 41,pp.1168-1174 (Co-authored)
84.	2007	Papers	An oral adsorbent, AST-120 protects against the progression of oxidative stress by reducing the accumulation of indoxyl sulfate in the systemic circulation in renal failure . Pharm Res 24,pp.1283-1289 (Co-authored)
85.	2007	Papers	Changes of net charge and α-helical content affect the pharmacokinetic properties of human serum albumin. Biochim Biophys Acta 1774,pp.1582-1590
86.	2007	Papers	Effect of olmesartan on oxidative stress in hemodialysis patients Hypertens Res 30,pp.395-402 (Co-authored)
87.	2007	Papers	The role of N-acetyl-methioninate as a new stabilizer for albumin products Int J Pharm 329,pp.19-24 (Co-authored)
88.	2006	Papers	Chromium(III) ion and thyroxine cooperate to stabilize the transthyretin tetramer and suppress in vitro amyloid fibril formation FEBS Lett 580,pp.491-496 (Co-authored)
89.	2006	Papers	Oxidation of Arg-410 promotes the elimination of human serum albumin Biochim Biophys Acta 1764,pp.743-749 (Co-authored)
90.	2006	Papers	The structural and pharmacokinetic properties of oxidized human serum albumin, advanced oxidation protein products (AOPP) Drug Metab Pharmacokinet 21,pp.140-146 (Co-authored)
91.	2005	Papers	Effect of genetic variation on the thermal stability of human serum albumin Biochim Biophys Acta 1747,pp.81-88 (Co-authored)
92.	2005	Papers	Effect of telmisartan on ABPM, plasma BNP, and oxidative status of serum albumin in hemodialysis patients Hypertens Res 28,pp.987-994 (Co-authored)
93.	2005	Papers	Hydrolysis of angiotensin II receptor blocker prodrug olmesartan medoxomil by human serum albumin and identification of its catalytic active sites Drug Metab Dispos 33,pp.1911-1919 (Co-authored)
94.	2005	Papers	Oxidation and carboxyl methyl lysine (CML)-modification of albumin; possible involvement in the progression of oxidative stress in hemodialysis patients Hypertens Res 28,pp.973-980 (Co-authored)
95.	2005	Papers	The structure and function of oxidized albumin in hemodialysis patients: Its role in elevated oxidative stress via neutrophil burst Biochem Biophys Res 334,pp.1322-1328 (Co-authored)
96.	2004	Papers	Intravenous iron administration induces oxidation of serum albumin in hemodialysis patients Kidney Int 66,pp.841-848 (Co-authored)
97.	2004	Papers	Kinetic studies of covalent binding between N-acetyl-L-cysteine and human serum albumin through a mixed-disulfide using an N-methylpyridinium polymer-based column Drug Metab. Pharmacokinet. 19,pp.297-302 (Co-authored)
98.	2004	Papers	Physicochemical characterization of cross-linked human serum albumin dimer and its synthetic heme hybrid as an oxygen carrier Biochim Biophys Acta 1675,pp.21-31 (Co-authored)
99.	2004	Papers	Stabilizing mechanisms in commercial albumin preparations: octanoate and N-acetyl-L-tryptophanate protect human serum albumin against heat and oxidative stress Biochim Biophys Acta 1702,pp.9-17 (Co-authored)
100.	2003	Papers	Validation of the chloramine-T induced oxidation of human serum albumin as a model for oxidative damage in vivo Pharm. Res 20,pp.684-692 (Co-authored)
101.	2001	Papers	Effect of oxidative stress on the structure and function of human serum albumin Pharm. Res 18,pp.632-639 (Co-authored)
102.	2000	Papers	Physicochemical characterization of a new crystal form and improvements in the pharmaceutical properties of the poorly water-soluble anti- osteoporosis drug 3,9-bis (N,N-dimethylcarbamoy-loxy)- 5H-benzofuro [3,2-c] quinoline-6-one (KCA-098) by solid dispersion with hydroxypropylcellulose Pharm. Dev. Technol 5,pp.443-454 (Co-authored)
103.	1999	Papers	Inhibition of rabbit heart carbonyl reductase by fatty acids Biol. Pharm. Bull 22,pp.731-733 (Co-authored)